494 related articles for article (PubMed ID: 16844683)
21. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils.
Bocharova OV; Breydo L; Salnikov VV; Baskakov IV
Biochemistry; 2005 May; 44(18):6776-87. PubMed ID: 15865423
[TBL] [Abstract][Full Text] [Related]
22. Prion protein amyloid formation under native-like conditions involves refolding of the C-terminal alpha-helical domain.
Cobb NJ; Apetri AC; Surewicz WK
J Biol Chem; 2008 Dec; 283(50):34704-11. PubMed ID: 18930924
[TBL] [Abstract][Full Text] [Related]
23. Distinct structures of scrapie prion protein (PrPSc)-seeded versus spontaneous recombinant prion protein fibrils revealed by hydrogen/deuterium exchange.
Smirnovas V; Kim JI; Lu X; Atarashi R; Caughey B; Surewicz WK
J Biol Chem; 2009 Sep; 284(36):24233-41. PubMed ID: 19596861
[TBL] [Abstract][Full Text] [Related]
24. Native, amyloid fibrils and beta-oligomers of the C-terminal domain of human prion protein display differential activation of complement and bind C1q, factor H and C4b-binding protein directly.
Sjöberg AP; Nyström S; Hammarström P; Blom AM
Mol Immunol; 2008 Jun; 45(11):3213-21. PubMed ID: 18406463
[TBL] [Abstract][Full Text] [Related]
25. Aggregation and fibrillization of the recombinant human prion protein huPrP90-231.
Swietnicki W; Morillas M; Chen SG; Gambetti P; Surewicz WK
Biochemistry; 2000 Jan; 39(2):424-31. PubMed ID: 10631004
[TBL] [Abstract][Full Text] [Related]
26. Detailed biophysical characterization of the acid-induced PrP(c) to PrP(β) conversion process.
Bjorndahl TC; Zhou GP; Liu X; Perez-Pineiro R; Semenchenko V; Saleem F; Acharya S; Bujold A; Sobsey CA; Wishart DS
Biochemistry; 2011 Feb; 50(7):1162-73. PubMed ID: 21189021
[TBL] [Abstract][Full Text] [Related]
27. Critical region for amyloid fibril formation of mouse prion protein: unusual amyloidogenic properties of the helix 2 peptide.
Yamaguchi K; Matsumoto T; Kuwata K
Biochemistry; 2008 Dec; 47(50):13242-51. PubMed ID: 19053276
[TBL] [Abstract][Full Text] [Related]
28. Self-assembly of recombinant prion protein of 106 residues.
Baskakov IV; Aagaard C; Mehlhorn I; Wille H; Groth D; Baldwin MA; Prusiner SB; Cohen FE
Biochemistry; 2000 Mar; 39(10):2792-804. PubMed ID: 10704232
[TBL] [Abstract][Full Text] [Related]
29. Self-Replication of Prion Protein Fragment 89-230 Amyloid Fibrils Accelerated by Prion Protein Fragment 107-143 Aggregates.
Sneideris T; Ziaunys M; Chu BK; Chen RP; Smirnovas V
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33049945
[TBL] [Abstract][Full Text] [Related]
30. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
[TBL] [Abstract][Full Text] [Related]
31. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
[TBL] [Abstract][Full Text] [Related]
32. Recombinant prion protein refolded with lipid and RNA has the biochemical hallmarks of a prion but lacks in vivo infectivity.
Timmes AG; Moore RA; Fischer ER; Priola SA
PLoS One; 2013; 8(7):e71081. PubMed ID: 23936256
[TBL] [Abstract][Full Text] [Related]
33. Pathway complexity of prion protein assembly into amyloid.
Baskakov IV; Legname G; Baldwin MA; Prusiner SB; Cohen FE
J Biol Chem; 2002 Jun; 277(24):21140-8. PubMed ID: 11912192
[TBL] [Abstract][Full Text] [Related]
34. Mammalian prion protein (PrP) forms conformationally different amyloid intracellular aggregates in bacteria.
Macedo B; Sant'Anna R; Navarro S; Cordeiro Y; Ventura S
Microb Cell Fact; 2015 Nov; 14():174. PubMed ID: 26536866
[TBL] [Abstract][Full Text] [Related]
35. Evidence for stepwise formation of amyloid fibrils by the mouse prion protein.
Jain S; Udgaonkar JB
J Mol Biol; 2008 Oct; 382(5):1228-41. PubMed ID: 18687339
[TBL] [Abstract][Full Text] [Related]
36. Conformational polymorphism of the amyloidogenic peptide homologous to residues 113-127 of the prion protein.
Satheeshkumar KS; Jayakumar R
Biophys J; 2003 Jul; 85(1):473-83. PubMed ID: 12829502
[TBL] [Abstract][Full Text] [Related]
37. Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein.
Selvaggini C; De Gioia L; Cantù L; Ghibaudi E; Diomede L; Passerini F; Forloni G; Bugiani O; Tagliavini F; Salmona M
Biochem Biophys Res Commun; 1993 Aug; 194(3):1380-6. PubMed ID: 8102526
[TBL] [Abstract][Full Text] [Related]
38. Osmolyte trimethylamine N-oxide converts recombinant alpha-helical prion protein to its soluble beta-structured form at high temperature.
Nandi PK; Bera A; Sizaret PY
J Mol Biol; 2006 Sep; 362(4):810-20. PubMed ID: 16949096
[TBL] [Abstract][Full Text] [Related]
39. Optimized overproduction, purification, characterization and high-pressure sensitivity of the prion protein in the native (PrP(C)-like) or amyloid (PrP(Sc)-like) conformation.
Alvarez-Martinez MT; Torrent J; Lange R; Verdier JM; Balny C; Liautard JP
Biochim Biophys Acta; 2003 Feb; 1645(2):228-40. PubMed ID: 12573253
[TBL] [Abstract][Full Text] [Related]
40. Structural insights into alternate aggregated prion protein forms.
Polano M; Bek A; Benetti F; Lazzarino M; Legname G
J Mol Biol; 2009 Nov; 393(5):1033-42. PubMed ID: 19720066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
